Adopt a stepped approach to atopic eczema management
Dr Caroline Ward discusses NICE recommendations on the treatment of atopic eczema, focusing on eczema complicated by bacterial or viral infection
Acne vulgaris: manage patient expectations and optimise treatment
Dr Kash Bhatti and Dr Bruce Pollock summarise the recently updated PCDS pathway on acne vulgaris and outline what to consider when managing the condition
Infective skin conditions: when is it appropriate to prescribe an antibiotic?
Dr Caroline Ward summarises updated NICE guidance on assessing and prescribing for impetigo, cellulitis and erysipelas, leg ulcer infection, and diabetic foot infections in primary care
Actinic keratosis: PCDS updates guidance on primary care management
Dr Kash Bhatti highlights recent updates to the PCDS pathway on actinic keratosis and considerations when assessing and managing this common condition
Key learning points: PCDS eczema
Dr Kash Bhatti presents five key learning points from updated Primary Care Dermatology Society guidance on eczema in adults and children
Educational resources
Implementing the NICE guideline on the management of acne vulgaris
Information intended for UK healthcare professionals only.
Methofill® (methotrexate) SelfDose for the treatment of adult patients with rheumatoid arthritis, Crohn’s disease, and psoriasis*
Intended for UK Healthcare professionals only.
This promotional supplement has been commissioned and funded by Accord-UK Ltd and developed in partnership with Guidelines in Practice.
Click here for Methofill® (methotrexate) prescribing information and adverse event reporting
For full indications, please consult the summary of product characteristics.
UK-03037 | Date of preparation: May 2021
Actinic keratosis (syn. solar keratosis)—Primary Care Dermatology Society
The production, printing, and distribution of this Guidelines reprint has been commissioned and funded by Almirall Ltd. Information intended for UK healthcare professionals only.
UK-ATK-2100001 March 2021
Recommending emollients for patients with atopic dermatitis or dry skin conditions
This supplement has been commissioned and funded by L’Oréal (UK) Limited and developed in partnership with Guidelines.
Date of preparation: January 2021